Skip to main content
. 2022 Aug 3;20(9):1793–1803. doi: 10.2174/1570159X19666211111123918

Fig. (2).

Fig. (2)

PANSS total score and subscores were significantly decreased after risperidone monotherapy for 12 weeks in both males and females (p < 0.01). Compared to males, females showed more improvement in positive symptoms (F = 5.4, p = 0.021). Note: *p<0.05.